日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

同时抑制 RAS-MAPK 通路和 PIKfyve 是胰腺癌的一种治疗策略

DeLiberty Jonathan M, Roach Mallory K, Stalnecker Clint A, Robb Ryan, Schechter Elyse G, Pieper Noah L, Taylor Khalilah E, Pita Lily M, Yang Runying, Bang Scott, Drizyte-Miller Kristina, Ackermann Sarah E, Nicewarner Peña Sheila R, Baldelli Elisa, Min Sophia M, Drewry David H, Petricoin Emanuel F 3rd, Morris John P 4th, Der Channing J, Cox Adrienne D, Bryant Kirsten L

Evaluating the Effect of KRAS Variants on Survival Outcomes and Therapy Response in Pancreatic Cancer

评估KRAS变异对胰腺癌生存结局和治疗反应的影响

Ebia, Matthew I; Blais, Edik M; Cui, Yujie; Petricoin, Emanuel F 3rd; Pishvaian, Michael; Gaddam, Srinivas; Gong, Jun; Osipov, Arsen; Hendifar, Andrew E

Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment

发育状态、p53状态和干扰素信号传导对胶质母细胞瘤细胞放射治疗和替莫唑胺治疗反应的影响

Berezovsky, Artem; Nuga, Oluwademilade; Datta, Indrani; Bergman, Kimberly; Sabedot, Thais; Gurdziel, Katherine; Irtenkauf, Susan; Hasselbach, Laura; Meng, Yuling; Mueller, Claudius; Petricoin, Emanuel F 3rd; Brown, Stephen; Purandare, Neeraja; Aras, Sidhesh; Mikkelsen, Tom; Poisson, Laila; Noushmehr, Houtan; Ruden, Douglas; deCarvalho, Ana C

Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma

角蛋白17是胰腺导管腺癌的预后和预测生物标志物

Delgado-Coka, Lyanne A; Roa-Peña, Lucia; Babu, Sruthi; Horowitz, Michael; Petricoin, Emanuel F 3rd; Matrisian, Lynn M; Blais, Edik M; Marchenko, Natalia; Allard, Felicia D; Akalin, Ali; Jiang, Wei; Larson, Brent K; Hendifar, Andrew E; Picozzi, Vincent J; Choi, Minsig; Shroyer, Kenneth R; Escobar-Hoyos, Luisa F

Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies

回顾性病例系列分析胰腺癌中RAF家族改变:靶向治疗和标准治疗的真实世界结果

Hendifar, Andrew; Blais, Edik M; Wolpin, Brian; Subbiah, Vivek; Collisson, Eric; Singh, Isha; Cannon, Timothy; Shaw, Kenna; Petricoin, Emanuel F 3rd; Klempner, Samuel; Lyons, Emily; Wang-Gillam, Andrea; Pishvaian, Michael J; O'Reilly, Eileen M

Author Correction: Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes

作者更正:结核病亚型中脂阿拉伯甘露聚糖抗原表位的差异

Magni, Ruben; Rruga, Fatlum; Alsaab, Fahad M; Sharif, Sara; Howard, Marissa; Espina, Virginia; Kim, Brianna; Lepene, Benjamin; Lee, Gwenyth; Alayouni, Mohamad A; Steinberg, Hannah; Araujo, Robyn; Kashanchi, Fatah; Riccardi, Fabio; Morreira, Sargento; Araujo, Antonia; Poli, Fernando; Jaganath, Devan; Semitala, Fred C; Worodria, William; Andama, Alfred; Choudhary, Alok; Honnen, William J; Petricoin, Emanuel F 3rd; Cattamanchi, Adithya; Colombatti, Raffaella; de Waard, Jacobus H; Oberhelman, Richard; Pinter, Abraham; Gilman, Robert H; Liotta, Lance A; Luchini, Alessandra

Increased PD-L1 Expression in Human Skin Acutely and Chronically Exposed to UV Irradiation

紫外线照射可导致人类皮肤中PD-L1表达增加(急性及慢性照射)

Dickinson, Sally E; Khawam, Maria; Kirschnerova, Viktoria; Vaishampayan, Prajakta; Centuori, Sara M; Saboda, Kathylynn; Calvert, Valerie S; Petricoin, Emanuel F 3rd; Curiel-Lewandrowski, Clara

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

接受分子分型后匹配治疗的胰腺癌患者的总生存期:一项基于“了解你的肿瘤”登记试验的回顾性分析

Pishvaian, Michael J; Blais, Edik M; Brody, Jonathan R; Lyons, Emily; DeArbeloa, Patricia; Hendifar, Andrew; Mikhail, Sam; Chung, Vincent; Sahai, Vaibhav; Sohal, Davendra P S; Bellakbira, Sara; Thach, Dzung; Rahib, Lola; Madhavan, Subha; Matrisian, Lynn M; Petricoin, Emanuel F 3rd

Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial

I-SPY 2 乳腺癌试验中预测 AKT 抑制剂疗效的作用机制生物标志物

Wolf, Denise M; Yau, Christina; Wulfkuhle, Julia; Brown-Swigart, Lamorna; Gallagher, Rosa I; Magbanua, Mark Jesus M; O'Grady, Nick; Hirst, Gillian; Asare, Smita; Tripathy, Debu; Berry, Don; Esserman, Laura; Chien, A Jo; Petricoin, Emanuel F 3rd; van 't Veer, Laura

A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience

迈向胰腺癌及相关癌症切除术后患者二线治疗个体化治疗的一步:一家机构的经验

Lowder, Cinthya Y; Dhir, Teena; Goetz, Austin B; Thomsett, Henry L; Bender, Joseph; Tatarian, Talar; Madhavan, Subha; Petricoin, Emanuel F 3rd; Blais, Edik; Lavu, Harish; Winter, Jordan M; Posey, James 3rd; Brody, Jonathan R; Pishvaian, Michael J; Yeo, Charles J